sequence under fasting conditions and at least 7 days washout period between the doses,A randomized&#44

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Levocetirizine Tablet (5 mg) relative to Xyzal® (Levocetirizine Tablet 5 mg) in healthy Thai volunteers under fasting condition

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Apixaban 5 mg tablets imported by Atlanta Medicare Co., Ltd. relative to Eliquis® 5 mg tablets, (hereinafter referred to as “Reference Preparation”) in healthy Thai volunteers under fasting condition